CellAct Pharma GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2007-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.cellact.eu
CAP7.1 for the Treatment of Advanced Stage, Therapy Refractory Lung and Biliary Tract Tumors
Phase 2
Terminated
- Conditions
- Advanced Endstage Solid Carcinomas in Adults
- Interventions
- Drug: CAP7.1
- First Posted Date
- 2014-03-24
- Last Posted Date
- 2018-09-05
- Lead Sponsor
- CellAct Pharma GmbH
- Target Recruit Count
- 45
- Registration Number
- NCT02094560
- Locations
- 🇩🇪
Charite, University Hospital, Berlin, Germany
© Copyright 2025. All Rights Reserved by MedPath